UMIN-CTR Clinical Trial

Basic information
Public title	Evaluation of effects of consumption of lactic acid bacteria on skin conditions of females
Acronym	Evaluation of effects of consumption of lactic acid bacteria on skin conditions of females
Scientific Title	Evaluation of effects of consumption of lactic acid bacteria on skin conditions of females
Scientific Title:Acronym	Evaluation of effects of consumption of lactic acid bacteria on skin conditions of females
Region	Japan

Condition
Condition	No
Classification by specialty	Adult
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	To investigate the effect of lactic acid bacteria on skin condition in healthy females.
Basic objectives2	Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	Skin hydration in stratum corneum and transepidermal water loss
Key secondary outcomes

Base
Study type	Interventional

Study design
Basic design	Parallel
Randomization	Randomized
Randomization unit	Individual
Blinding	Double blind -all involved are blinded
Control	Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms	2
Purpose of intervention	Prevention
Type of intervention	Food
Interventions/Control_1	A beverage containing lactic acid bacteria (130 mL/day for 8 weeks)
Interventions/Control_2	A beverage not containing lactic acid bacteria (130 mL/day for 8 weeks)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	20 years-old <=
Age-upper limit	60 years-old >
Gender	Female
Key inclusion criteria	1. Japanese healthy females aged 20 to 59 years-old at acquisition of the consent. 2. Who have subjective symptoms of dry skin 3. Who can make self-judgment, voluntarily agreed to participate to this study, and provide written informed consent.
Key exclusion criteria	1. Who have any disease 2. Who take any medicines or foods which affect intestinal flora 3. Who take any medicines or foods which affect skin moisture 4. Who have allergic to apple, soy bean, dairy food 5. Who had surgery or treatment on skin within two months 6. Who expose to high-intensity ultraviolet rays. 7. Who are pregnant or breast-feeding or willing to be pregnant during this study. 8. Who have participated in other clinical study for skin during this study, or willing to be that. 9. A person of irregular habits. 10, Who are judged unsuitable for this study by principal investigator.
Target sample size	100

Research contact person
Name of lead principal investigator	1st name Shigenori Middle name Last name Suzuki
Organization	KAGOME CO., LTD.
Division name	Nature & Wellness Research Department
Zip code	329-2762
Address	17 Nishitomiyama, Nasushiobara city, Tochigi
TEL	0287-36-2935
Email	Shigenori_Suzuki@kagome.co.jp

Public contact
Name of contact person	1st name Naoko Middle name Last name Waki
Organization	KAGOME CO., LTD.
Division name	Nature & Wellness Research Department
Zip code	329-2762
Address	17 Nishitomiyama, Nasushiobara city, Tochigi
TEL	0287-36-2935
Homepage URL
Email	Naoko_Waki@kagome.co.jp

Sponsor
Institute	KAGOME CO., LTD.
Institute
Department

Funding Source
Organization	KAGOME CO., LTD.
Organization
Division
Category of Funding Organization	Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor	Kirei Testing Labo Co., Ltd.
Name of secondary funder(s)

IRB Contact (For public release)
Organization	Kagome Ethics Committee
Address	3-21-1, F tower, Hamacho, Nihonbashi, Tyuo-ku, Tokyo, Japan
Tel	03-5623-8501
Email	Takuji_Hayakawa@kagome.co.jp

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions	株式会社きれいテストラボ（東京都）／Kirei Testing Labo Co., Ltd. (Tokyo, Japan)

Other administrative information
Date of disclosure of the study information	2019 Year 10 Month 15 Day

Related information
URL releasing protocol
Publication of results	Published

Result
URL related to results and publications
Number of participants that the trial has enrolled	99
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Main results already published
Date of protocol fixation	2019 Year 08 Month 27 Day
Date of IRB	2019 Year 08 Month 27 Day
Anticipated trial start date	2019 Year 10 Month 16 Day
Last follow-up date	2019 Year 12 Month 19 Day
Date of closure to data entry	2020 Year 01 Month 31 Day
Date trial data considered complete
Date analysis concluded	2020 Year 03 Month 31 Day

Other
Other related information

Management information
Registered date	2019 Year 10 Month 15 Day
Last modified on	2020 Year 06 Month 30 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043434